Box score
Matchpoint Therapeutics Inc.
Reported $68.4M sold in a new Form D filed November 20, 2026 (Massachusetts).
- Biggest raise
- $68.4M filed Nov 20, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Massachusetts
- Season rank
- #34 of 1,212 in the Bio & Health League; #401 of 11,716 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-11-20 | New notice | $68.4M | $150M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1950915.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Alzheon, Inc. | Bio & Health | $78.8M |
| 2 | Ratio Therapeutics, Inc. | Bio & Health | $70M |
| 3 | Superluminal Medicines, Inc. | Bio & Health | $65.5M |
| 4 | Stipple Bio, Inc. | Bio & Health | $65.1M |
| 5 | Terrestrial Bio, Inc. | Bio & Health | $57.3M |
| 6 | Typewriter Therapeutics, Inc. rookie | Bio & Health | $56.3M |